D
Arbutus Biopharma Corporation ABUS
$3.59 $0.010.28% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 2.52M -24.53M -12.53M -19.72M -19.80M
Total Depreciation and Amortization 11.00K 330.00K 333.00K 336.00K 356.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -43.00K 5.54M 2.11M 1.14M 2.18M
Change in Net Operating Assets -18.24M 5.27M -229.00K -2.50M 2.76M
Cash from Operations -15.75M -13.39M -10.32M -20.74M -14.50M
Capital Expenditure -- -- -86.00K 0.00 -1.00K
Sale of Property, Plant, and Equipment 9.00K -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 15.60M 11.35M 13.50M -11.99M 9.83M
Cash from Investing 15.61M 11.35M 13.41M -11.99M 9.83M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 453.00K 2.78M 1.42M 1.78M 24.37M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 453.00K 2.78M 1.42M 1.78M 24.37M
Foreign Exchange rate Adjustments 21.00K 4.00K -33.00K 5.00K -8.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 336.00K 746.00K 4.48M -30.94M 19.69M